Free Newsletter
Ranbaxy's Singhs are $100M wealthier this year
Free newsletter via e-mail
Tools
The latest Forbes rich list showed the trials and travails of the globe's most wealthy: the number of billionaires on the planet dropped last year. But India's "pharmaceutical kings" Malvinder and Shivinder Singh--of Ranbaxy Laboratories fame--actually added $100 million to their combined net worth. Thank you, Daiichi Sankyo! Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: